BioCryst Pharmaceuticals
BCRX
#4703
Rank
NZ$2.70 B
Marketcap
$12.96
Share price
2.48%
Change (1 day)
64.91%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$1.41 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is NZ$1.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.43 B9.9%
2023-12-31NZ$1.30 B11.73%
2022-12-31NZ$1.16 B34.46%
2021-12-31NZ$0.86 B124.21%
2020-12-31NZ$0.38 B208.18%
2019-12-31NZ$0.12 B36.38%
2018-12-31NZ$92.16 M19.62%
2017-12-31NZ$77.05 M-0.65%
2016-12-31NZ$77.55 M75.89%
2015-12-31NZ$44.09 M15.16%
2014-12-31NZ$38.28 M4.88%
2013-12-31NZ$36.5 M0.11%
2012-12-31NZ$36.46 M-5.13%
2011-12-31NZ$38.43 M
2000-12-31NZ$0.02 M
1997-12-31NZ$0.17 M-59.42%
1996-12-31NZ$0.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$1.19 B-15.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.34 B 66.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.61 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.40 B-71.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$46.57 B 3,202.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.64 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.17 B 2,535.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$1.15 B-17.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.33 M-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA